PhD studentship in Biochemistry/Biology at Max Plank Institute

The Laboratory of “Lymphocyte Signaling and Oncoproteome” under Dr. med. Marco Herling at the Department of Internal Medicine I (Chair Prof. Dr. med. M. Hallek) at the University Hospital of Cologne, Germany, is looking for a full-time PhD student in academic cancer research starting her/his position in May – June 2009.


The position is open for a 3-4 year project on the topic of Interrogation of the contribution of TCL1 in molecular cascades of antigen receptor signaling of malignant B-cells in the context of lymphoma initiation and progression.

This work includes in vitro cell line systems, primary cell (co)cultures, and the study of engineered animals, all with respect to protein (kinase) interactions and receptor affinity.

We are looking for a highly motivated candidate with sufficiently practical research experience as well as theoretical background in the above field of lymphocyte cell signaling. Please refrain from applying if you can not prove experience in the above area.


The candidate should have had exposure to a broad variety of techniques in molecular biology and protein biochemistry and have aquired a strong background in immunology.


Our main focus are the mechanisms of oncogenic transformation in lymphocytes to be exploited for clinical applications in the future. Our institution is one of 4 German officially accredited Excellence Centers in Oncology. In addition, we are also part of the new CECAD initiative clustering the most renowned research teams of the Cologne Campus in the field of aging research with exclusive curricula and facilities. Our department is the home of Europe’s largest clinical trial group in chronic lymphocytic leukemia.

We are a young and ambitious 7-person team (2 post-doc’s, 3 PhD students, 1 Research Technician, 1 MD student) embedded in an excellent environment of multiple expertises and collaborations at the Medical School main campus. This 3-4 year degree-granting work in our laboratory will also be part of an enrollment in the Graduate School for Biomedical Sciences (GSfBS) with a multidisciplinary Thesis committee. It would expose the candidate to a variety of experimental methods of protein detection, isolation and biochemistry, as well as techniques in molecular biology and experimental immunology, using cancer models and patient material.Basic requirements for this position are a Diploma / Masters in the natural sciences as well as proficiency in basic methods of molecular biology and cell signaling research. In order to be approved by the GSfBS, the candidate must have completed a single continuous 9 months – 1 year experimental Masters / Diploma work. We will give preference to candidates with additional (extracurricular) under- or postgraduate (after Diploma / Masters) training with proven productivity (publications).The application should comprize a CV including a photograph and undergraduate grades (German Abiturnoten), list of technical expertise, two phone numbers of people providing references, and your contact information. The application deadline is March 31st, 2009. The application process includes written questionnaires and interviews subsequent to the submission of the above requested information.We are looking forward to your application.For further information please contact Dr. M. Herling under +49 221 478-5465 or -5194 or at marco.herling@uk-koeln.de


Or visit our web-site:

http://www.uk-koeln.de/kliniken/innere1/forschung/e_lab_lymphocyte


Signaling Oncoproteome University of Cologne


Website:

http://www.uk-koeln.de/klinik…


Location:

Cologne Medical School Campus, CECAD Campus, GSfBS Campus, Max-Planck Institute
Campus

Expires:
May 18, 2009

PhD Fellowships in Biochemistry at Friedrich Schiller University, Germany

JSMC invites applications for a PhD Fellowship on the topic Chemical crosstalk among bacterial
predators

The genus Lysobacter constitutes a physiologically unique group of organisms within the
proteobacteria that practices wolf pack behavior to prey on other microbes. The research project is focused on the identification and characterisation of chemical factors that trigger or mediate
group predation using methods of molecular biology and analytical chemistry.

We expect:
- a Master’s degree (or equivalent) in Microbiology, Biochemistry or Chemistry. Candidates about
to earn their degree are welcome to apply.
- high motivation and interest to join one of the interdisciplinary research areas of JSMC
- creativity and interest to shape your own thesis project
- an integrative and cooperative personality
- very good communication skills in English (instruction language at JSMC)

We offer:
- a highly communicative atmosphere within a scientific network providing top?level researchconditions
- a PhD stipend paid for 3 years according to the rules of the DFG (German Research Foundation)
as well as generous research funding
- a comprehensive mentoring program with efficient supervision by a team of supervisors
- courses in novel technologies and soft skills
- Jena - the German City of Science 2008: a young and lively city with dynamic business
activities,successful scientific centres of innovation and a vibrant cultural scene around the
famous Friedrich
Schiller University

Friedrich Schiller University Jena is an equal opportunity employer.

The application procedure is handled online exclusively via the JSMC website www.jsmc.uni.jena.de

Please visit this website to acquaint yourself with details about the project above and other PhD
projects offered within the current JSMC Recruitment Call. Then complete and submit the
‘Statement of Interest’ form downloadable from www.jsmc.uni.jena.de. Applications can only be
considered upon receipt of the completed form, submitted by email to apply.jsmc@uni.jena.de.
DO NOT submit any additional documents at this point.

Deadline for submission of the ‘Statement of Interest’: April 6th, 2009.

Selected applicants will be invited to the JSMC Recruitment Meeting in Jena, Germany, at the end of June,2009. PhD fellowship awarding decisions will be made shortly thereafter (July 2009).